[Elsevier] Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial |
|
This post will be closed automatically in 2026-06-18 13:22
Reward10points
|
10
Alumni social networks and hedge fund performance: Evidence from China
10
Expert Transformer: Fine-Grained Mixture-of-Experts for Time-Series forecasting
15
Multifunctional saponin-based nanocarriers for targeting oral delivery of hydrophobic drugs: linking molecular architecture with bioavailability enhancement
10
Infectious keratitis associated with contact lens wear: REGINFECOR multicenter study
10
The emergence of empathy: A developmental neuroscience perspective
